FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutics, and concerns a dosage form presented in the form of a capsule having a shell wall, a linker or another capsule subunit consisting of a pharmaceutically acceptable composition containing (i) ammonium methacrylate copolymer type A (Eudragit RL), (ii) at least one excipient modifying dissolution and presenting a hydroxypropyl cellulose polymer blend of various molecular weights and (iii) a lubricating agent.
EFFECT: invention provides polymer compositions applicable for melt extrusion and injection moulding, enabling time variations of shell dissolution and components release from the capsule.
32 cl, 12 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITIONS | 2007 |
|
RU2445077C2 |
| MULTI-COMPONENT GRADUATED PHARMACEUTICAL FORM | 2003 |
|
RU2325153C2 |
| CONTROLLED-RELEASE HYDROCODON COMPOSITION | 2001 |
|
RU2253452C2 |
| SOLID TABLETS AND CAPSULES OF MODIFIED RELEASE OF BENZONATATE | 2014 |
|
RU2673239C2 |
| SYSTEMS OF DELIVERING MEDICAL SUBSTANCES, INCLUDING WEAKLY BASIC MEDICINAL SUBSTANCES AND ORGANIC ACIDS | 2009 |
|
RU2504362C2 |
| COATING COMPOSITION SUITABLE FOR PHARMACEUTICAL OR NUTRICEUTICAL DOSAGE FORMS | 2011 |
|
RU2606588C2 |
| COATING COMPOSITION SUITABLE FOR PHARMACEUTICAL OR NUTRICEUTICAL DOSAGE FORMS | 2011 |
|
RU2599023C2 |
| COMPOSITIONS OF ORALLY DISPERSIBLE TABLETS CONTAINING COMBINATIONS OF HIGH- AND LOW-DOSE THERAPEUTIC AGENTS | 2010 |
|
RU2554740C2 |
| PER ORALLY DECOMPOSING TABLET COMPOSITIONS, CONTAINING COMBINATIONS OF NON-OPIATE ANALGESICS | 2010 |
|
RU2567032C2 |
| ORAL PHARMACEUTICAL COMPOSITIONS OF NICOTINAMIDE | 2017 |
|
RU2738114C2 |
